Varaico: Literature-Extracted Genetic Variants

Gene:CFTR
Variant:p.L467F
Back to variants list

CFTR

NM_000492.4:p.L467F

Associated Papers

Variable Response to Elexacaftor/Tezacaftor/Ivacaftor in [L467F;F508del] Homozygous Patients: A Case Series.

Akgül Erdal M et al.

Pediatric Pulmonology, 2026

L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?

Kondratyeva E et al.

International Journal of Molecular Sciences, 2025

Cystic fibrosis risk variants confer protection against inflammatory bowel disease.

Yu M et al.

Cell Genomics, 2025

41330381 (PubMed )
Supplement: mmc3.xlsx › Sheet1

Genetically engineered approaches to the treatment of cystic fibrosis.

Safrygina AA et al.

Biophysical Reviews, 2025

Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical features, genetic characteristics, and treatment outcomes.

Zou Y et al.

Bmc Gastroenterology, 2025

The Spectrum and Carrier Frequencies of Common Pathogenic Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Men from the General Population: The Role of Ethnicity.

Osadchuk L et al.

International Journal of Molecular Sciences, 2025

Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators.

Tümmler B et al.

Molecular and Cellular Pediatrics, 2025

Human Induced Lung Organoids: A Promising Tool for Cystic Fibrosis Drug Screening.

Demchenko A et al.

International Journal of Molecular Sciences, 2025

Case Report: Pitfalls in CF screening - targeted variant analysis can cause misleading results and therapy recommendations.

Karnstedt M et al.

Frontiers in Genetics, 2025

Cystic fibrosis risk variants confer protection against inflammatory bowel disease.

Yu M et al.

Medrxiv : the Preprint Server for Health Sciences, 2024

39677473 (PubMed )
Supplement: media-1.xlsx › ST3

Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics.

Yıldız CA et al.

Pediatric Pulmonology, 2024

Effect of the Complex Allele p.[Ile148Thr;Ile1023_Val1024del] in Cystic Fibrosis and Tracing of a Founder Effect in Mexican Families.

Mendiola-Vidal NG et al.

Life (basel, Switzerland), 2024

Population Characteristics of the Spectrum and Frequencies of CFTR Gene Mutations in Patients with Cystic Fibrosis from the Republic of Bashkortostan (Russia).

Ayupova G et al.

Genes, 2024

Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene.

Efremova A et al.

International Journal of Molecular Sciences, 2024

CFTR complex alleles and phenotypic variability in cystic fibrosis disease.

El-Seedy A et al.

Cellular and Molecular Biology (noisy-le-grand, France), 2024

Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.

Stahl M et al.

The European Respiratory Journal, 2024

38901883 (PubMed )
Supplement: ERJ-00004-2024.Supplement.pdf

Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.

Kay DM et al.

Pediatric Pulmonology, 2024

Exploring the diversity of CFTR gene mutations in cystic fibrosis individuals of South Asia.

Rafique H et al.

The Journal of Asthma : Official Journal of the Association for the Care of Asthma, 2024

Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.

Fevola C et al.

European Journal of Pediatrics, 2024

Advances in the Study of Common and Rare CFTR Complex Alleles Using Intestinal Organoids.

Krasnova M et al.

Journal of Personalized Medicine, 2024

Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.

McDonald EF et al.

Biorxiv : the Preprint Server for Biology, 2024

37873426 (PubMed )
Supplement: media-3.xlsx › Sheet1

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.

McDonald EF et al.

Plos One, 2024

38271453 (PubMed )
Supplement: pone.0297560.s009.xlsx › Supp_Table_2

Study of the genetic and molecular epidemiology of cystic fibrosis based on the patient registry for planning targeted therapy in Russian Federation.

Kondratyeva E et al.

Frontiers in Genetics, 2024

The Effect of Complex Alleles of the CFTR Gene on the Clinical Manifestations of Cystic Fibrosis and the Effectiveness of Targeted Therapy.

Krasnova M et al.

International Journal of Molecular Sciences, 2023

Identification of cystic fibrosis transmembrane conductance regulator gene (CFTR) variants: A retrospective study on the western and southern regions of Saudi Arabia.

Almaghamsi T et al.

Saudi Medical Journal, 2023

Clinical and Genetic Characteristics of a Patient with Cystic Fibrosis with a Complex Allele [E217G;G509D] and Functional Evaluation of the CFTR Channel.

Kondratyeva E et al.

Genes, 2023

Variability of the sweat test in children with Cystic Fibrosis previously CRMS/CFSPID: A retrospective monocenter experience.

Terlizzi V et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 2023

Patient-derived cell models for personalized medicine approaches in cystic fibrosis.

Ramalho AS et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 2023

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor.

Tümmler B

Frontiers in Pharmacology, 2023

Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.

Allan KM et al.

Frontiers in Molecular Biosciences, 2023

Personalized Selection of a CFTR Modulator for a Patient with a Complex Allele [L467F;F508del].

Kondratyeva E et al.

Current Issues in Molecular Biology, 2022

Evaluation of the Complex p.[Leu467Phe;Phe508del] CFTR Allele in the Intestinal Organoids Model: Implications for Therapy.

Kondratyeva E et al.

International Journal of Molecular Sciences, 2022

Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series.

Terlizzi V et al.

Journal of Personalized Medicine, 2022

C FTR variants are associated with chronic bronchitis in smokers.

Saferali A et al.

The European Respiratory Journal, 2022

Accounting for population structure in genetic studies of cystic fibrosis.

Kingston H et al.

Hgg Advances, 2022

35647563 (PubMed )
Supplement: mmc1.pdf

High frequency of complex CFTR alleles associated with c.1521_1523delCTT (F508del) in Russian cystic fibrosis patients.

Petrova NV et al.

Bmc Genomics, 2022

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs.

Sondo E et al.

International Journal of Molecular Sciences, 2022

CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.

Alibakhshi R et al.

Pediatric Pulmonology, 2021

Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR.

Baatallah N et al.

Cellular and Molecular Life Sciences : Cmls, 2021

Frequency of allele variations in the CFTR gene in a Mexican population.

Cantú-Reyna C et al.

Bmc Medical Genomics, 2021

34740355 (PubMed )
Supplement: 12920_2021_1111_MOESM1_ESM.xlsx › Hoja1

Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening.

Sicko RJ et al.

International Journal of Neonatal Screening, 2021

1–50 of 79 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."